Judge orders Hegseth to explain US military’s new testosterone policy
Summary
A federal judge has asked the Trump administration to explain why the military is offering testosterone treatment to older male soldiers but bans such hormone treatments for transgender troops. The new policy checks male soldiers over 30 for low testosterone and offers therapy to improve their physical readiness. The judge wants clarity on the differences in how hormone treatments are handled for transgender versus cisgender service members.Key Facts
- The Defense Secretary announced that male soldiers aged 30 and older will be screened for low testosterone levels.
- Soldiers with low testosterone can choose to receive testosterone replacement therapy (TRT).
- A federal judge questioned why hormone treatments are allowed for cisgender soldiers but banned for transgender troops under Trump’s military ban.
- The judge cited President Trump’s executive order banning transgender troops from receiving hormone treatment as a medical necessity.
- The judge requested the Pentagon explain the reason for treating transgender and cisgender military members differently.
- Medical experts expressed concern that unnecessary testosterone therapy may harm soldiers’ health and fertility.
- The Pentagon has raised cost concerns about providing hormone treatments to transgender troops.
- The next court hearing on this issue is scheduled for August 7.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
